Paul Field

Paul Field is supporting Servatus to engage with potential partners for its SVT-IC469 Helicobacter pylori program. He has over 25 years of business development experience across a range of therapeutic areas, and a deep network in the global biopharmaceutical industry. His current roles include corporate advisory positions at Imunexus, Alsonex, Marinova, and the Global Antibiotic R&D Partnership (GARDP) headquartered in Geneva. He was previously the life sciences specialist at Austrade, the Australian Government’s investment promotion agency, where he facilitated foreign direct investment into Australian research in infectious diseases, autoimmune diseases, cancer and other therapeutic areas. Paul has served on a number of Boards, and he is a Fellow of the Australian Institute of Company Directors (FAICD).